Staphylococcus aureus (S. aureus) is a virulent bacterium that abundantly colonizes inflammatory skin diseases. Since S. aureus infections occur in an impaired skin barrier, it is important to understand the protective mechanism through cutaneous immune responses against S. aureus infections and the interaction with Staphylococcal virulence factors.
INTRODUCTION
Staphylococcus aureus (S. aureus) most commonly causes skin infections where the skin barriers are impaired from multiple factors, including wounding [1] . S. aureus infections show minor symptoms without spreading to other sites and are easily treated with antibiotics. However, these infections can become more invasive and cause life-threatening infections such as bloodstream infections, pneumonia, abscesses, endocarditis, and surgical site infections [2] [3] [4] .
Moreover, methicillin-resistant staphylococcus aureus (MRSA) is a problem to communities and healthcare settings [5] . The rates of infections linked to MRSA are soaring, and MRSA is currently the leading cause of invasive illness, resulting in more fatalities worldwide. A recent study in the US demonstrated that 76% of all bacterial infections in emergency rooms were identified as MRSA stains [5] .
It is well accepted that barrier functions of the skin localize to the stratum corneum (SC), the outer-most layer of the skin [6] . The SC deploys various barrier functions to defend an organism from external insults, and pathogenic microbes, including S. aureus, and to maintain internal homeostasis. Although the composition of SC, e.g., pH, contents of water, lipids, and antimicrobial peptides, is optimized to prevent bacterial infection and growth, changes in these factors due to barrier disruption increase the susceptibility to infection [7] [8] [9] .
In this review, we summarize the pathogenesis of the most virulent bacteria S. aureus infections, and cutaneous immune responses against their infections and colonization.
The information obtained from this area will provide the groundwork for further immunomodulatory therapies or vaccination strategies, which help to prevent S. aureus infections. 
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Staphylococcus aureus (S. aureus) AND ITS VIRULENCE FACTORS
S. aureus is a gram-positive opportunistic pathogen that is normally found on the skin and nose of appropriately 25-30% of healthy adults and in 25% of hospital workers [9, 10] . Colonization provides a reservoir from which bacteria can be introduced, usually resulting in a localized collection of pus, known as an abscess or furuncle, cellulitis, impetigo, and scalded skin syndrome [11] . Once S. aureus disseminate into the bloodstream and spread to the organs, the organism spreads widely to peripheral sites in the distant organs, leading to serious illnesses known as bacteremia, sepsis, osteomyelitis, and infective endocarditis [12, 13] . The prevalence of these infections has apparently increased owing to higher rates of colonization, immunosuppression, a greater use of surgical implants, and dramatic increases in antibiotic resistance [3] . It is critical to understand the mechanisms of skin S. aureus colonization, which is an important risk factor for subsequent infection (Fig. 1) . [18, 19] . The strain responsible for these infections is the USA400 clonal type strain (also called MW2 strain) [20] .
Subsequently, other clonal outbreaks of skin infection by MRSA were also reported among prison inmates, soldiers, and athletes. The strain responsible for these infections was USA300 (LAC strain) [21] . More recently, some clonal strains of S. aureus have been identified to be resistant to the antibiotic vancomycin, the last drug to which the organism had been uniformly sensitive [22] . These organisms are known to be vancomycin-intermediate-resistant S. aureus (VISA) and vancomycin-resistant Staph aureus (VRSA).
Microbial surface components recognizing adhesive matrix molecules
The extracellular matrix (ECM) is the extracellular part of the multicellular structure that provides physical structural and biochemical support to the surrounding cells, such as cell adhesion, migration, and differentiation [23] . In addition, ECM also provides the attachment of colonizing microorganisms [24] . Many microorganisms express cell surface adhesions that mediate microbial adhesion to the ECM of the host tissue. Over the last 20 years, the genomes of many isolates of S. aureus have been sequenced and different assays have been employed to identify virulence factors associated with colonization or invasion [25] . When S. aureus colonization occurs in the skin, human extracellular matrix proteins, e.g., fibronectin, fibrinogen, laminin, elastin, and collagen recognize invaded S. aureus [23, 26] . This ECM binding adhesin family is called microbial surface components recognizing adhesive matrix molecules (MSCRAMMs)
[27] ( as LPS does in Gr-inflammation and infection [36] [37] [38] .
Note that the strains deleted in LTA synthesis genes showed a dramatic reduction in staphylococcal skin and/or systemic infections.
DEFENSIVE SKIN BARRIER
Skin has three structure layers: 1) epidermis, the outermost layers of skin, provides multiple defensive barrier and creates our skin tone; 2) dermis contains hair follicles and sweat glands; and 3) the subcutaneous tissue is made of fat and connextive tissue [39] . Moreover, the outer layer of skin, the epidermis, consists of four separate layers, stratum basale (SB), stratum spinosum (SP), stratum granulosum (SG) and stratum corneum (SC). Because the epidermis, particularly the SC, is positioned at an interface between the internal and external environment, the primary role of the SC is to protect our body from external stresses, including infectious microbes [39] .
The composition of the skin is optimized to prevent the growth pathogenic microbes, e.g, low pH and structural sphingolipids [39] . In particular, the skin contains multifunctional, specialized peptides that provide cutaneous immune defense through their activity against pathogenic microorganisms [39, 40] .
CUTANEOUS IMMUNE DEFENSES
The cutaneous immune system develops two distinct defense mechanisms, innate and adaptive immune systems (hBDs) [43, 44] .
Of these AMPs, CAMP is the first AMP found in the skin. The Vitamin D3-mediated Vitamin D Receptor (VDR) activation is the primary transcriptional regulatory mechanism of CAMP generation in the skin [44, 45] . Alternatively, we recently demonstrated that subtoxic external stresses such as UVB irradiation that induce endoplasmic reticulum (ER) stress and increase cellular ceramide production in parallel with stimulated metabolic conversion of sphingosine to sphingosine-1-phosphate (S1P) lead to enhanced CAMP production via an NF-κB activation, independent of the VDR pathway [46, 47] . Although a detailed mechanism of how the ER stress-mediated increase in S1P activates NF-B still remains unresolved, our recent studies further demonstrated that CAMP generation likely occurs by an S1P receptor independent mechanism (Fig. 2) .
CAMP has potent, broad-spectrum antimicrobial activities against virulent S. aureus. It is generally accepted that CAMP disrupts the integrity of the cell membrane of S. aur- eus, which accounts for their ability to kill invaded S. aureus [40, 48] . In addition to antimicrobial activity, CAMP is known to have other functions, e.g., cytokine production, cellular differentiation, and adaptive immunity [49] .
Interestingly, CAMP expression is highly increased in skin wounds, and decreased after wound closure, suggesting an important role of CAMP in wound healing [50] .
Another major epidermal AMP is hBDs, which have a wide range of antimicrobial activity and keratinocytes expressing hBD-1, hBD-2, and hBD-3 [43, 51] . While hBD-1 is constitutively expressed in the skin, both hBD-2 and hBD-3 are upregulated by membrane receptors, cytokines, or external stresses such as UVB irradiation. Toll-like receptors (TLR) 4, which are evolutionarily conserved pattern recognition receptors, can recognize a bacterial virulence factor, lipopolysaccharides (LPS), increasing the hBD-2 expression in the skin [52] . Moreover, IL-1 regulates hBD-2 production, whereas hBD-3 induction is influenced primarily by IL-6, suggesting that different inducible factors or regulatory mechanisms are responsible for the generation of various hBDs [43, 51, 53] . Although hBD-2 has no antimicrobial activity against Gram-positive S. aureus, which is the virulent bacteria that colonizes approximately 90% of atopic dermatitis (AD) patients, recent studies revealed that hBD-2 combined with another major AMP, hBD-3 and/or CAMP, has synergistic antimicrobial activity by effectively killing S. aureus [43, 51] .
In addition to innate immunity, prior studies have demonstrated that the formyl peptide receptor-like (FPRL)1, which is a receptor of CAMP, activates the chemotaxis of neutrophils, monocytes, and CD4 T cells [51, 54] . Moreover, hBDs induce the migration of adaptive immune cells via the CC chemokine receptors (CCR) on memory T cells and immature dendritic cells (CCR6), as well as on monocytes and mast cells (CCR2), suggesting that both epidermal AMPs, CAMP and hBDs can link to adaptive immune response [51, 54] (Fig. 2) .
CONCLUSIONS
Healthy human skin is optimized to prevent the infection/colonization of S. aureus, the most common species of staphylococcus on the skin. However, S. aureus infections of the skin occur in impaired skin caused by numerous factors, including certain skin diseases or wounds. To provide cutaneous immune defense against these infection/colonization, major epidermal AMPs initially function to kill S. aureus.
In addition to antimicrobial ability, another role of AMPs is adaptive immune response via activating chemotaxis and/or migration of immune cells, such as T cells, neutrophils, and monocytes (Fig. 2) .
